These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28970136)

  • 41. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.
    Varma V; Cohen C
    Adv Anat Pathol; 2004 Sep; 11(5):239-49. PubMed ID: 15322490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Wang C; Shao X; Zhang X; Xie C; Yu J; Xu X; Yang J; Li Y; Xu W
    Transl Cancer Res; 2020 Jan; 9(1):128-136. PubMed ID: 35117166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
    Choi WT; Ramachandran R; Kakar S
    Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arginase-1 is More Specific Than Hepatocyte Paraffin 1 for Differentiating Hepatocellular Carcinomas With Cytoplasmic Clearing from Nonhepatocellular Clear Cell Tumors in Liver Biopsies.
    Larson BK; Dhall D; Guindi M
    Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):37-43. PubMed ID: 37859468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocellular carcinoma: diagnosis by percutaneous fine needle biopsy.
    Bret PM; Labadie M; Bretagnolle M; Paliard P; Fond A; Valette PJ
    Gastrointest Radiol; 1988 Jul; 13(3):253-5. PubMed ID: 2838372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatoid Teratoma, Hepatoid Yolk Sac Tumor, and Hepatocellular Carcinoma: A Morphologic and Immunohistochemical Study of 30 Cases.
    Al-Obaidy KI; Williamson SR; Shelman N; Idrees MT; Ulbright TM
    Am J Surg Pathol; 2021 Jan; 45(1):127-136. PubMed ID: 32991342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical expression of manganese superoxide dismutase in hepatocellular carcinoma, using a specific monoclonal antibody.
    Aida Y; Maeyama S; Takakuwa T; Uchikoshi T; Endo Y; Suzuki K; Taniguchi N
    J Gastroenterol; 1994 Aug; 29(4):443-9. PubMed ID: 7951854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
    Shan Q; Chen J; Zhang T; Yan R; Wu J; Shu Y; Kang Z; He B; Zhang Z; Wang J
    Abdom Radiol (NY); 2017 Aug; 42(8):2079-2088. PubMed ID: 28337521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytodiagnosis of well differentiated hepatocellular carcinoma: can indeterminate diagnoses be reduced?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 1999 Oct; 87(5):270-7. PubMed ID: 10536352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological and prognostic implications of arginase expression in hepatocellular carcinoma.
    Mao H; Gao W; Lu G; Fang F; Teng L
    Clin Lab; 2013; 59(1-2):37-43. PubMed ID: 23505904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in arginase isoenzymes pattern in human hepatocellular carcinoma.
    Chrzanowska A; Krawczyk M; Barańczyk-Kuźma A
    Biochem Biophys Res Commun; 2008 Dec; 377(2):337-340. PubMed ID: 18831962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma.
    Choi WT; Kakar S
    Gastroenterol Clin North Am; 2017 Jun; 46(2):311-325. PubMed ID: 28506367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology.
    Bakheet AMH; Zhao C; Chen JN; Zhang JY; Huang JT; Du Y; Gong LP; Bi YH; Shao CK
    Hepatol Int; 2020 Jan; 14(1):96-104. PubMed ID: 31832976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclooxygenase-2 expression in hepatocellular carcinoma.
    Shiota G; Okubo M; Noumi T; Noguchi N; Oyama K; Takano Y; Yashima K; Kishimoto Y; Kawasaki H
    Hepatogastroenterology; 1999; 46(25):407-12. PubMed ID: 10228831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biopsy-proven Hepatocellular Carcinoma in a 53-year-old Woman With Arginase Deficiency.
    Koo M; Lipshutz GS; Cederbaum SD; Lassman C
    Pediatr Dev Pathol; 2017; 20(6):517-521. PubMed ID: 29187023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.